Young Plasma Infusion.

What it is

Young plasma infusion grew out of parabiosis research at Stanford and Harvard, where joining the circulation of old and young mice improved muscle repair, brain function and liver regeneration in the older mice. The idea is that young blood carries signaling factors that decline with age.

In people, the approach means infusing plasma from young donors, sometimes after therapeutic plasma exchange (TPE) removes some of a person's own plasma. Human data is limited to small studies and case reports, and the FDA has cautioned that young plasma has no established benefit for aging.

What happens at a visit

1. A conversation with a qualified physician about research options and registered trials.
2. Medical screening and baseline labs, such as inflammatory markers.
3. Donor plasma screened for infections and quality, as with any transfusion.
4. An IV infusion of about 1 to 2 hours.
5. Some research protocols pair it with plasma exchange first.
6. Possible tiredness for a day or two afterward.

Who it is for

• People following longevity research closely
• People who qualify for a registered clinical trial
• People already working with a physician on plasma exchange
• People willing to join a study or wait for human data

Evidence and safety

The evidence is mostly from animals: mouse parabiosis studies are strong and have been repeated. Human data is limited to small studies and case series without clear benefit, and the FDA has warned that young plasma has no established benefit for aging and carries risks. Those include allergic and other transfusion reactions and, rarely, infection. Anyone interested should talk with a qualified physician and look for a registered clinical trial.

How Gabriel helps